Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

127.78
Delayed Data
As of Apr 28
 +0.87 / +0.69%
Today’s Change
109.12
Today|||52-Week Range
157.02
+4.44%
Year-to-Date
Alexion Rises More Than 5% After Beating Consensus
Apr 27 / TheStreet.com - Paid Partner Content
Biotech Movers: Pacific Biosciences Falls After Net Loss Spikes
Apr 27 / TheStreet.com - Paid Partner Content
Alexion (ALXN) Tops Q1 Earnings, Revenues; Ups '17 View
Apr 27 / Zacks.com - Paid Partner Content
Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports
Apr 27 / TheStreet.com - Paid Partner Content
Alexion (ALXN) Tops Q1 Earnings, Sales; Shares Up
Apr 27 / Zacks.com - Paid Partner Content
Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?
Apr 21 / Zacks.com - Paid Partner Content
NJ State Employees Deferred Compensation Plan Buys Enbridge, Alexion Pharmaceuticals,...
Apr 27 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: FDA CRL Hits Incyte, Pipeline Setbacks Weigh on OncoMed
Apr 19 / Zacks.com - Paid Partner Content